EPHA2 and Familial prostate cancer: After characterizing and selecting the most effective complex based on cellular uptake efficiency, cytotoxicity, and EphA2 gene silencing efficiency in prostate cancer cells, its anticancer effect with epigenetic agent JIB-04 on cell viability (2D and 3D tumor spheroids), migration, and colony formation was evaluated in vitro.